Objectives: To characterize the mechanisms involved in reduced susceptibility to carbapenems in two Enterobacter cloacae clinical isolates.
Introduction
GIM-1 (German imipenemase) is a carbapenemase that was first identified in five clonally related Pseudomonas aeruginosa clinical isolates recovered in North Rhine-Westfalia, Germany, in 2004. 1 Five other GIM-1-producing P. aeruginosa isolates were then reported in the same region in 2012. 2 GIM-1 is an Ambler class B metallo-b-lactamase (MBL) that is distantly related to other acquired MBLs, with the most closely related being DIM-1 (55% amino acid identity). The bla GIM-1 gene was found to be located on plasmids, however, their transferability (either by conjugation or by transformation) has not been demonstrated. 1 -3 The bla GIM-1 gene cassette was found to be embedded in a class 1 integron structure, together with the b-lactamase gene bla OXA-2 , and the aminoglycoside resistance genes aacA4 and aadA1.
1 Whereas other MBL genes such as bla IMP , bla VIM , and bla NDM have been found either in P. aeruginosa or Enterobacteriaceae, the occurrence of bla GIM-1 had only been described in P. aeruginosa and then recently in a single Serratia marcescens isolate. 3 We report here the identification of bla GIM-1 in two Enterobacter cloacae isolates and describe its plasmid and genetic context.
Materials and methods

Bacterial isolates
The first isolate was obtained in 2011 from a 78-year-old man who was admitted to the University Hospital of Cologne for the treatment of a partial middle cerebral artery infarction. The patient had a urethral infection that grew E. cloacae 1 that was resistant to ertapenem and meropenem. The infection subsided after local antiseptic treatment without antibiotic therapy. The second isolate was obtained in 2012 from a 78-year-old patient who had been admitted for the treatment of a Susceptibility, phenotypic and molecular testing for b-lactamase production Production of extended-spectrum b-lactamases (ESBLs) was investigated by a double disc synergy test (DDST) using ticarcillin/clavulanate and aztreonam (which is not a substrate of GIM-1). Production of carbapenemases was evidenced by using the Carba NP test as described. 4 MBL production was investigated by a DDST using a meropenem disc and a blank disc impregnated with 10 mL 0.1 M EDTA. Detection of the bla VIM , bla IMP , bla GIM-1 , bla NDM-1 , bla OXA-48 and bla KPC carbapenemase genes was performed by PCR, followed by sequencing. 5 A similar approach was used to search for the ESBL genes bla CTX-M , bla SHV , bla TEM , and for the class D b-lactamase genes bla OXA-1 and bla OXA-10 .
6 Susceptibility testing by agar diffusion was performed and interpreted according to CLSI guidelines. 7 MICs of carbapenems were evaluated by Etest (bioMér-ieux, La Balme-les-Grottes, France) and interpreted according to the CLSI; colistin MIC was interpreted according to EUCAST 8 in the absence of a CLSI breakpoint.
Clonal relatedness and outer membrane analysis
The clonal relationship of the two E. cloacae isolates was investigated by rep-PCR using the DiversiLab system dedicated for Enterobacter (bioMér-ieux, La Balme-les-Grottes, France) following the manufacturer's recommendations. The outer membrane protein (OMP) profiles of the two E. cloacae isolates were analysed to explain the higher carbapenem resistance level observed for isolate 1. OMP studies were performed using SDS-PAGE as described previously. 9 
Conjugation and transformation assays
The transferability of the bla GIM-1 gene was evaluated by a mating-out assay using sodium azide-resistant E. coli J53 as recipient as described previously. 6 Transconjugants were obtained after plating on tryptic soy agar containing sodium azide (100 mg/L) and cefoxitin (30 mg/L) as selective agents. Transformation of the plasmid from isolate 1 into P. aeruginosa strain PU21 was done by electroporation as described. 10 Transformants were selected on ticarcillin (100 mg/L)-containing agar plates.
Plasmid analysis
Plasmid DNA was extracted using the Plasmid Maxi Prep Kit and the Large Construct Kit (Qiagen, Hilden, Germany). The estimation of plasmid size was done by S1 nuclease treatment of plasmid DNA and agarose gel electrophoresis. Restriction fragment length polymorphism (RFLP) analysis of plasmids was performed using restriction enzymes KpnI, ApaI, HindIII, BamHI and NotI. Partial sequencing of the bla GIM-1 -bearing natural plasmid of isolate 1 was done by primer walking. Plasmid incompatibility groups were determined by a PCR-based replicon typing (PBRT) method. 11 
Results
Susceptibility, molecular and phenotypic testing for b-lactamases
Both isolates were resistant to ceftazidime and ertapenem, but remained susceptible to imipenem, cefepime and aztreonam (Table 1) , and to the non-b-lactam antibiotics amikacin, gentamicin, fosfomycin, and colistin. Isolate 2 was additionally susceptible to meropenem, ciprofloxacin and co-trimoxazole. In isolate 1, the MICs of ertapenem and meropenem, but also of some other b-lactams, were higher than in isolate 2 ( Table 1 ). This discrepancy was probably the result of two features of isolate 1: the production of b-lactamase OXA-2 in combination with a decreased outer membrane permeability linked to the loss of an OMP (data not shown).
ESBL testing by DDST was negative for both isolates, and PCR analyses confirmed the absence of ESBL-encoding genes. In contrast, modified Hodge test (MHT) and DDST with meropenem and EDTA was positive for both isolates, thus strongly suggesting production of an MBL. PCR screening for carbapenemase genes identified the bla GIM-1 gene in both isolates, which was confirmed by subsequent DNA sequencing. Molecular typing by rep-PCR showed that the two isolates had a similarity of only 75.9%, thereby showing that they were non-clonal.
Plasmid background and genetic context of the bla GIM-1 gene
Analysis of the plasmid content of the two E. cloacae isolates revealed a plasmid of 24 kb in isolate 1 and of .50 kb in isolate 2. Both plasmids were self-transferable to E. coli J53 by conjugation. Interestingly, the 24 kb plasmid was successfully transferred and replicated in P. aeruginosa PU21, but the same experiment failed with the plasmid extract obtained from isolate 2.
E. coli J53 transconjugants expressing GIM-1 showed a 2-fold increase in MICs of imipenem and meropenem, and a .60-fold MIC increase for ertapenem ( Table 1 ). The MIC of aztreonam was not modified, in accordance with the lack of hydrolysis of that substrate by GIM-1.
1 MICs of the P. aeruginosa transformant (TF PU21) were significantly higher than those of E. coli J53 transconjugants. As expected, this transformant exhibited resistance to carbapenems, but noticeably the MICs of cefepime and cefpirome were considerably increased, with only the aztreonam MIC remaining unchanged (Table 1 ). These discrepancies with what was observed in E. coli might be explained by the intrinsic weak permeability of P. aeruginosa for b-lactams playing a synergistic role with the MBL production.
PBRT analysis did not give any positive amplicon for the two E. coli transconjugants, thus suggesting that the plasmid carrying the bla GIM-1 gene did not correspond to the common and widespread plasmid types usually spreading antibiotic resistance genes among Enterobacteriaceae. RFLP analysis of the two plasmids that had a similar size (isolate 1 and P. aeruginosa 7312198) showed that the plasmid structures were different, thus ruling out any relationship between them.
Genetic context of the bla GIM-1 gene
Sequencing of the close genetic environment of bla GIM-1 revealed a class 1 integron structure. In isolate 1, the class 1 integron contained four gene cassettes, namely bla GIM-1 , aacA4, aadA1 and bla OXA-2 , similar to the integron previously identified in P. aeruginosa (Figure 1) . Interestingly, insertion sequence IS1394 GIM-1-producing E. cloacae 559 JAC identified inside the integron in P. aeruginosa was absent here. In isolate 2, the bla GIM-1 gene was also embedded in a class 1 integron structure, but contained only an additional gene cassette downstream of bla GIM-1 , namely aadB, encoding resistance to aminoglycosides (Figure 1) .
Discussion
This study constitutes the first report of the bla GIM-1 gene in E. cloacae. This gene was located on different self-transferable plasmids. One plasmid was 24 kb in size, which is similar to that reported in P. aeruginosa ( 22 kb).
1 That plasmid harboured a very similar integron structure, and replicated in P. aeruginosa, thus suggesting that such a broad-host-range plasmid could be the vehicle responsible for spreading the bla GIM-1 gene among distantly related Gram-negative species. In contrast, the second isolate harboured a different type of plasmid, probably of narrow host range.
Interestingly, while this work was in progress, a bla GIM-1 -positive Serratia marcescens isolate was identified in North RhineWestfalia, 3 thus highlighting the current emergence of this carbapenemase in Enterobacteriaceae at least in that region. In that latter strain, the integron structure was identical to the one we identified in isolate 1. In contrast to what has been hypothesized by Rieber et al., 3 we do not consider those plasmids found in Enterobacteriaceae to directly originate from P. aeruginosa. If this was the case, one identical plasmid would be expected to be present in all strains. Rather, we speculate that the bla GIM-1 gene cassette has successfully targeted different class 1 integrons located on different plasmid scaffolds.
The isolation of two unrelated E. cloacae strains from different parts of Germany indicates that GIM-1 is no longer confined to a small geographical area as previously thought. Considering that the laboratory recognition of GIM-positive isolates as carbapenemase producers is challenging (especially when ertapenem is not routinely tested), the bla GIM-1 gene might be more widespread among Enterobacteriaceae than currently known.
(c) Figure 1 . Class 1 integron structures identified in the bla GIM-1 -carrying isolates: (a) isolate 1; (b) isolate 2; (c) P. aeruginosa reference strain. Hamprecht et al.
